EichorEICHOR
Location: Bridgewater Synced from ClinicalTrials.gov · August 11, 2026

Clinical studies recruiting near Bridgewater

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Phase 4 · Viable Clinical Research - Bridgewater · Alimentiv Inc. · NCT06257706A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Phase 2 · Viable Clinical Research Corporation · Pfizer · NCT07575932A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Mult
Phase N/A · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT06433752Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Phase 3 · Advanced Heart Care LLC · Novo Nordisk A/S · NCT06118281Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Phase 3 · Research Site · DalCor Pharmaceuticals · NCT05918861A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a
Phase 3 · Advanced Heart Care, LLC · Boehringer Ingelheim · NCT06935370Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Phase 4 · University of Sydney · NCT02823821Avalglucosidase Alfa Pregnancy Study
Phase N/A · Investigational site worldwide · Sanofi · NCT05734521Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Phase 3 · Advanced Heart Care, LLC · Cytokinetics · NCT06736574MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Performance Surgical Associates · Stryker Instruments · NCT03072927A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Phase 3 · Advanced Heart Care LLC · Amgen · NCT07037459Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Perc
Phase 4 · Advanced Heart Care LLC · Duke University · NCT06909565A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase 3 · Advanced Heart Care, LLC · Boehringer Ingelheim · NCT06424288EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · Advanced Heart Care, LLC · Boehringer Ingelheim · NCT07064473LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or A
Phase 3 · Viable Clinical Research · Boehringer Ingelheim · NCT06632444LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Viable Clinical Research · Boehringer Ingelheim · NCT06632457OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Advanced Heart Care LLC · Amgen · NCT07136012
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.